| Line 135: |
Line 135: |
| | | | |
| | ===Lupus erythematosus=== | | ===Lupus erythematosus=== |
| | + | |
| | + | *'''Systemic (SLE)''' |
| | + | **Multiple organs involved |
| | + | **Cats, dogs, horses |
| | + | **Immune dysregulation: |
| | + | ***Damaged T-cell suppressor function, either primary deficiency or antibody mediated |
| | + | ***Cytokine dysregulation |
| | + | ***Resulting B-cell hyperactivity -> antibodies to self antigens -> antigen-antibody complexes deposited in various tissues -> Type III hypersensitivity |
| | + | **Lesions localised or generalised |
| | + | **Erythema, alopecia, depigmentation, crusting and scaling, ulceration |
| | + | **Microscopically: lymphohistiocytic interface dermatitis, thickened basement membrane, vasculitis, subepidermal vesicles, basal cell degeneration |
| | + | *'''Discoid''' |
| | + | **Milder variant of systemic |
| | + | **Depigmentation, erythema, scaling, erosions, ulceration, crusting |
| | + | **Usually involves nasal planum, dorsum of muzzle, occasionally pinnae, lips, oral mucosa or periocular area |
| | + | **Microscopically: lichenoid interface dermatitis, often with lymphocytes, plasma cells, basal cell degeneration, loss of pigment |
| | | | |
| | ===Pemphigus=== | | ===Pemphigus=== |